找回密碼
 To register

QQ登錄

只需一步,快速開始

掃一掃,訪問微社區(qū)

打印 上一主題 下一主題

Titlebook: Virus Entry Inhibitors; Stopping the Enemy a Shibo Jiang,Lu Lu Book 2022 The Editor(s) (if applicable) and The Author(s), under exclusive l

[復(fù)制鏈接]
樓主: ACRO
31#
發(fā)表于 2025-3-27 00:45:04 | 只看該作者
32#
發(fā)表于 2025-3-27 03:57:32 | 只看該作者
Endogenous Peptide Inhibitors of HIV Entry,SDF-1/CXCL12 inhibits specific viral strains. The knowledge that RANTES, MlP-1α, and MlP-1β specifically inhibit other primary HIV-1 strains allowed the rapid discovery of CCR5 as second major viral coreceptor and explained why individuals with deletions in CCR5 are protected against sexual HIV-1 tr
33#
發(fā)表于 2025-3-27 09:13:41 | 只看該作者
34#
發(fā)表于 2025-3-27 12:40:39 | 只看該作者
35#
發(fā)表于 2025-3-27 14:40:56 | 只看該作者
36#
發(fā)表于 2025-3-27 21:40:42 | 只看該作者
Broad-spectrum Respiratory Virus Entry Inhibitors,ile more than 260 viruses are known to infect humans, only a small minority of these viral diseases are treatable by clinically approved antiviral drugs. Apart from these identified viruses, new emerging viruses and drug-resistant viruses are also important challenges to our public health and health
37#
發(fā)表于 2025-3-27 22:46:06 | 只看該作者
Ebola Virus Entry Inhibitors,ugh two monoclonal antibody (mAb) drugs have recently received approval in the USA, additional therapeutics are still needed to combat potential outbreaks of resistance variants and other closely related ebola viruses. In this chapter, we describe the current understanding of the EBOV entry process
38#
發(fā)表于 2025-3-28 03:04:38 | 只看該作者
39#
發(fā)表于 2025-3-28 07:45:18 | 只看該作者
Entry Inhibitors of Hepatitis B and D Viruses, the major cause of chronic hepatitis, liver failure, cirrhosis, and hepatocellular carcinoma (HCC). In nature, HBV and HDV have a narrow host range and highly hepatotropic, only infecting the hepatocytes of humans and a few primates. The elucidation of cell entry mechanism by HBV has made great pro
40#
發(fā)表于 2025-3-28 13:13:21 | 只看該作者
 關(guān)于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務(wù)流程 影響因子官網(wǎng) 吾愛論文網(wǎng) 大講堂 北京大學(xué) Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點評 投稿經(jīng)驗總結(jié) SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學(xué) Yale Uni. Stanford Uni.
QQ|Archiver|手機版|小黑屋| 派博傳思國際 ( 京公網(wǎng)安備110108008328) GMT+8, 2026-1-16 10:54
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved
快速回復(fù) 返回頂部 返回列表
衡东县| 云安县| 麻栗坡县| 新龙县| 普陀区| 夏津县| 成武县| 乐安县| 故城县| 布尔津县| 高清| 宜丰县| 方山县| 陈巴尔虎旗| 四子王旗| 盐池县| 西平县| 岢岚县| 苍溪县| 公主岭市| 南华县| 铜山县| 钟山县| 肃宁县| 奉新县| 祁阳县| 荔浦县| 延边| 安乡县| 墨玉县| 阿克| 黔东| 苏州市| 启东市| 抚顺市| 江山市| 开化县| 饶河县| 玉环县| 德江县| 宁陕县|